FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions refers to the chemical-pharmaceutical industry and is an ophthalmic aqueous liquid preparation, as well as ophthalmic solution containing (3-{2-[4-isopropyl-2-(4-trifluoromethyl)phenyl-5-thiazolyl]ethyl}-5-methyl-1,2-benzisoxazol-6-yl) oxyacetic acid or a pharmaceutically acceptable salt thereof and benzalkonium chloride, where the preparation or solution has a transmittance at a wavelength of 600 nm of not less than 98%.
EFFECT: group of inventions also includes a method for clarifying this aqueous liquid preparation and allows to obtain a colorless, clear ophthalmic aqueous solution capable of preventing the appearance of whitish opacity.
25 cl, 13 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE AQUEOUS SOLUTION | 2014 |
|
RU2665639C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES | 2009 |
|
RU2477631C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS, CONTAINING BORATE-POLYOL COMPLEXES | 2010 |
|
RU2563125C2 |
| PHARMACEUTICAL COMPOSITION OF TAFLUPROST | 2021 |
|
RU2761625C2 |
| OPHTHALMIC FORMULATIONS FOR DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2768489C2 |
| OCULAR COMPOSITIONS FOR DRUG-DELIVERY TO POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2665953C2 |
| WATER-BASED LIQUID COMPOSITION WITH BROMFENAC POSSESSING PRESERVATIVE EFFECTIVENESS | 2012 |
|
RU2625755C2 |
| COMPOSITION IN THE FORM OF EYE DROPS TO DECREASE INTRAOCULAR PRESSURE | 2017 |
|
RU2772230C2 |
| OPHTHALMIC FORMULATIONS FOR DRUG DELIVERY AND ANTERIOR EYE PROTECTION | 2015 |
|
RU2768652C1 |
| COMPOSITIONS AND METHODS OF USING CHOLINE ESTER OF LIPOIC ACID | 2015 |
|
RU2735790C2 |
